Background-Although exercise induced desaturation can occur in patients with chronic obstructive pulmonary disease (COPD), little is known about its frequency during everyday exercise, or how it relates to dyspnoea or prior drug treatment. 
oxitropium bromide, an anticholinergic bronchodilator drug, on spirometric values, dyspnoea score, and oxygen saturation during corridor walking and cycle ergometry were studied in a double blind, randomised, placebo controlled study. Results-Oxitropium produced a small increase in forced expired volume in one second (FEVy) from 0'76 (0.28) 1 to 0'93 (0.69) 1 and in six minute walking distance from 311 (93) m to 332 (86) m, but did not change progressive cycle exercise duration. Resting and end exercise breathlessness levels were reduced in both forms of exercise after oxitropium. Resting oxygen saturation fell significantly after active bronchodilator from 92-9% (3.7%) to 92-0% (4.1%) but the nadir saturation during exercise was unchanged. The patients desaturated more during corridor walking than cycle ergometry [walking 7-8% (4.4%), cycle ergometry 2-1% (2-1%)]. Baseline walking distance was related to FVC, resting breathlessness and resting oxygen saturation (multiple r2 = 0.46) but only resting saturation correlated with end exercise breathlessness (r' = -0.25).
Improvements in symptoms or exercise performance after oxitropium could not be predicted by changes in spirometric indices or oxygen saturation. Conclusions-In patients with COPD arterial oxygen desaturation during selfpaced walking is common, of greater severity than that during cycle ergometry, but is unaffected by inhaled oxitropium bromide. The factors that predict initial performance are not appropriate markers of functional improvement after an active bronchodilator drug.
(Thorax 1993;48:1145-1150) Exertional breathlessness and reduced exercise tolerance are important features of chronic obstructive pulmonary disease (COPD) and are usually attributed to a reduced ventilatory capacity.' 2 Arterial oxygen desaturation can occur in these patients3-6 but its frequency and severity during everyday exercise is controversial as is its relationship to breathlessness.7 Most data have come from cycle ergometer or treadmill exercise tests which may not be directly relevant to usual exercise patterns. 8 Resting oxygen saturation can be affected by adrenergic bronchodilators such as isoprenaline or orciprenaline, whether intravenous or inhaled, which cause small but significant falls in resting Pao2 in obstructive lung disease. The one anticholinergic drug so far studied, however, did not.9-11 Anticholinergic drugs can reduce dyspnoea and improve exercise performance even in patients who do not meet the usual criteria of bronchodilator reversibility.'2 This might be due to improvements in exercise related oxygen desaturation as exercise with supplementary oxygen is known to reduce breathlessness and increase exercise performance in normoxic patients with COPD."3
The advent of relatively portable and accurate pulse oximeters"4 has meant that the relation of oxygen desaturation to everyday exercise such as self-paced corridor walking can be investigated. We have used the opportunities provided by a double blind randomised crossover trial of the anticholinergic agent oxitropium bromide to investigate: (1) how frequently oxygen desaturation occurs during corridor walking and whether it differs in severity from that during cycle ergometry; (2) whether short term bronchodilatation in patients with COPD influences resting and exercise induced desaturations; and (3) whether spirometric indices, oxygen saturation, and gas transfer factor singly or in combination predict walking distance or intensity of breathlessness, and whether changes in these variables can predict subsequent improvements in exercise performance and symptoms after the anticholinergic drug. To examine the relation between walking distance, spirometric measurements, Sao2 and TLCO a stepwise multiple linear regression was constructed with six minute distance as the dependent variable. A similar procedure was used to relate resting dyspnoea to spirometric values, Sao2, and TLCo. Since these relationships may be altered by the bronchodilator, further equations were constructed to relate the change in walking distance and change in dyspnoea to the changes in these variables.
Methods

Results
There was a practice effect on six minute walking distance (6MD) between days 1 and 2, but thereafter the baseline 6MD, symptom scores and resting Sao, did not differ between study days (table 1). The subgroup in whom The level of oxygen saturation at rest before the first walk was correlated with resting FEV, (r = 0 4, p < 0-005) and with the walking distance achieved (r = 0-48, p < 0-001).
In contrast, FEV, and FVC correlated with walking distance less strongly (r = 0-32 and 0-31 respectively, p < 0-05). The resting saturation in the group who had to stop was less than in those who completed the walk without stopping (92-1% (3-7%) v 93-6% (2-1%), p < 0-05). During the walk oxygen desaturation occurred in 42 of the 48 subjects. The largest desaturations occurred in those patients with the lowest resting oxygen saturation (who also had the worst spirometric measurements) (fig 1) . In the 33 patients who walked continuously oxygen saturation declined steadily during the first three minutes of the six minute walk (fig 2A and B) (table 2) . The duration of exercise did not correlate with the resting oxygen saturation. The degree of desaturation during the cycle exercise (2-1% (2-1%)) was significantly less (p < 0-001) than that during corridor walking (7-8% (4.4%)) (fig 3) , while the breathlessness scores at the cycle ergometry were greater than those at the walking test (p < 0-001).
ANTICHOLINERGIC BRONCHODILATATION AND EXERCISE DESATURATION
Oxitropium bromide increased FEVy and FVC (FEVy before oxitropium 0-76 (0-28) 1, after oxitropium 0-93 (0-69) 1, p < 0-001). There was a modest but significant improvement in six minute walking distance of 29-4 This equation explained 46% of the residual variance of walking distance. The same variables, together with nadir oxygen saturation, were included in further stepwise regression analyses using either resting or end of walk breathlessness as dependent variables. No factor predicted resting breathlessness, while only resting oxygen saturation was a significant predictor of end of walk dyspnoea (r= -0 5, p < 0001). The improvements in walking distance, resting and end of walk breathlessness after the bronchodilator were unrelated to changes in either FEV, FVC, resting, or nadir saturations.
(57-8) m after oxitropium (p < 0-001). Both resting and end of walk breathlessness were significantly less after active bronchodilator (p < 0002 and <0-001 respectively) (table 2).
The resting saturation for the whole group fell slightly but consistently after oxitropium bromide from 92-9% (3.7%) to 92-0% (4-1%) (p < 0-005). These changes were not related to the degree of bronchodilation. Arterial desaturation during the walk was not affected by oxitropium despite the lower postbronchodilator resting saturations and the greater walking distance achieved.
In those patients who stopped during the walk, neither the time to the first stop nor the saturation at the time of the first stop were affected by the bronchodilator. There were no differences in the peak heart rates during the walks before or after active drug.
The duration of cycle exercise was unaffected by oxitropium bromide compared with placebo (3-8 (2-1) min v 4-1 (2-2) min). However, maximum oxygen consumption (Vo2) and minute ventilation (E) increased significantly after bronchodilator, whilst the end of exercise breathlessness score fell (p < 0-002) (table 2). When breathlessness was calculated at equivalent levels of ventilation, the changes after oxitropium were most marked at the highest levels of ventilation with significant reductions in both breathlessness and respiratory frequency in these conditions. However oxygen desaturation was no different ( Desaturation is most likely to occur and become severe in those patients with the lowest resting Sao,, but the sigmoid nature of the haemoglobin dissociation curve means that changes in oxygen tension are likely to be similar. In contrast, oxygen desaturation during cycle ergometry before the active drug was infrequent, despite the greater effort involved as judged by dyspnoea scoring. Previous studies comparing treadmill exercise and cycle ergometry at similar workloads show that desaturation was greater during treadmill walking,'9 but this is the first demonstration of the effect during self-paced corridor exercise.
Previous studies in patients with severe COPD suggest that increases in venous admixture and relative hypoventilation during exercise are the major causes of desaturation.820 The relation we saw between resting Sao2 and the severity of the subsequent desaturation during walking is in keeping with such a mechanism, as is the rapid resaturation at the end of exercise. We could not measure ventilation directly during the selfpaced walks and differences between the tests may be explained by differences in metabolic load and the breathing pattern adopted. Lactate production is higher during treadmill walking at the same workload than during cycle ergometry, while there are differences in the pattern of recruitment of accessory muscles between the two settings.2122 Whatever -gn the mechanism, our data show that cycle ergometry will consistently underestimate the severity of desaturation during less intense but more prolonged self-paced exercise.
Oxitropium bromide is an inhaled anticholinergic drug similar to ipratropium bromide but with a somewhat longer duration of action.23 The present study extends our earlier observation that oxitropium increases corridor walking distance and reduces resting and exercise breathlessness when compared with placebo.12 In neither study were these changes related to the changes in spirometric indices recorded at rest, and in this report we found similar symptomatic benefit from oxitropium during cycle ergometry. A previous study using atropine methonitratell reported similar changes in ventilation and oxygen consumption during cycle exercise to those we saw after oxitropium, but this earlier study did not include an assessment of symptoms. We found a proportionately larger effect of the active drug on symptoms than on other measured physiological variables. This may reflect a lack of proportionality in the Borg scale, although this has not been reported in earlier validation studies.2425
Arterial oxygen desaturation after bronchodilator drugs has been reported previously,9 10 but principally in patients with asthma and after adrenergic bronchodilatation. In a study of 12 Like Mak et al we failed to find a relation between exercise duration and resting breathlessness.6 Resting Sao2 was the only factor predictive of end exercise dyspnoea but this relation is not necessarily causal. While some groups believe that hypoxia is an independent stimulus to dyspnoea,7 there is good evidence that abolishing hypoxia improves breathlessness simply by reducing the minute ventilation26 and our post-bronchodilator data support this. After oxitropium resting Sao2 fell but so did resting breathlessness, while the improvement in 6MD was unrelated to changes in resting or exercise induced desaturation. During cycle exercise after oxitropium more subjects desaturated, but dyspnoea at equivalent ventilations was less and the respiratory rate was slower, implying that mechanical rather than gas exchange factors were the most important ones.
Our data show that patients with stable severe COPD experience large and normally unsuspected periods of hypoxaemia, the duration of which will vary with the amount of exercise taken. This hypoxic burden may contribute to complications such as secondary polycythaemia seen in COPD. 27 Bicycle ergometry can provide useful information about the metabolic response to exercise and maximum performance but underestimates the desaturations seen during self-paced exercise. The political arguments for the need to isolate South Africa in the battle against apartheid received widespread support. The lack of any adequate moral basis for the intellectual impoverishment which accompanied the academic boycott led to the concept of selective support as an appropriate means of openly declaring against apartheid and all its abhorrent effects, without succumbing to intimidating and coercive forces implicit in academic boycott inimical to intellectual and professional pursuits.
As South Africa lurchingly gropes its way into a better future in which dignity will hopefully be restored to all its citizens, we shall rely heavily on our internal personal resources (contributed to by our constructively critical and yet supportive colleagues) and on intellectual and material support from the industralised world. Tuberculosis, smoking related lung diseases, AIDS, asthma, occupational lung disease, and lung cancer are all major and growing problems in Africa. Collaborative, scientific and social research at many levels could offer mutual benefits.
Our dilemmas-a microcosm of issues underlying global instability-represent the opportunity to show that the wide disparities produced by generations of greed, exploitation, and denegration of other cultures can be addressed and reversed through rational, empathetic and peaceful means.
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